Framol-Med GmbH

At Framol-Med GmbH, the clinical research focus is centered on Respiratory Tract Diseases, with studies exploring both asthma and chronic obstructive pulmonary disease. The trials are designed to assess how well new and existing inhaled and biologic treatments can improve symptom control, reduce flare-ups, and support better long-term lung health.

• Evaluating combination inhaler therapies for better control of chronic breathing disorders
• Studying treatments aimed at reducing COPD exacerbations and related complications
• Assessing new options for asthma management in adolescents and adults

This research includes efforts to compare treatment effectiveness against standard care or placebo, helping clarify which approaches may offer the greatest benefit for patients with moderate-to-severe COPD and related respiratory conditions.

The Pulmonology department at this hospital is conducting multiple trials focused on COPD, including more advanced forms of the disease. These studies are examining therapies intended to reduce worsening episodes, improve breathing outcomes, and address the needs of people living with persistent airway inflammation.

• Testing whether biologic therapies can lower the frequency of COPD attacks
• Comparing treatment strategies to improve cardiopulmonary outcomes
• Exploring new approaches for patients with type 2 inflammation and chronic airway disease

The overall goal is to generate clearer evidence on how emerging therapies may help patients with moderate-to-severe COPD achieve better disease control and quality of life.

Research at Framol-Med GmbH also includes asthma, with trials looking at the effectiveness and safety of combination inhaled therapy. These studies aim to improve everyday symptom management and provide better options for people whose asthma remains difficult to control.

• Evaluating inhaled combination treatments for symptom relief and disease control
• Comparing active therapy with placebo to measure treatment benefit
• Supporting better care for adolescents and adults with persistent asthma

This area of research is focused on understanding whether newer treatment combinations can offer more effective control than current approaches while maintaining safety in routine respiratory care.